CClinicalTrials.gg
TerminatedNCT03715270Presygen™Updated Jun 10, 2019

Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device

An observational study in Perfusion; Complications, sponsored by Christie Medical Holdings, Inc.. Terminated at 1 site in United States. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-10.

Sponsored by Christie Medical Holdings, Inc. · Observational

Why this study was terminated
Sponsor decision to end study.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
6
Ages
22 Years and older
Sex
All
01

Study summary

This study is designed to evaluate the information provided to the clinicians by the surgical imaging device. It is also to gain insight on the user interface and how "user friendly" it is to the clinician.

Read the detailed description

Over the last decade, objective ways of measuring tissue oxygen have been introduced into the medical arena and are being used more and more for assessing ischemic events in tissue. Handheld Doppler ultrasound, infrared thermography, polarized spectral imaging, laser Doppler perfusion imaging, and fluorescence imaging have all been used with some degree of success. However, only a few have gained universal acceptance. [1] Multispectral imaging (MSI) which uses near-infrared (NIR) light to measure tissue oxygen levels in superficial tissue is another method that has been successfully used to assess tissue flap health.

The objective of this study is to conduct an evaluation of superficial tissue with Presygen™/si-1 in various patient types for surgical imaging during breast reconstruction. In addition, participating surgeons will complete a structured survey regarding their assessment of Presygen™/si-1 work station during the surgical procedure.

Primary Goal: Evaluation of superficial tissue in various patient types for surgical imaging during breast reconstruction.

Secondary Goal: Surgeon assessment of surgical work station during surgery through a prepared questionnaire.

02

Conditions studied

  • Perfusion; Complications
03

In context

Lead sponsor

Christie Medical Holdings, Inc. is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients undergoing breast reconstruction surgery and meet the inclusion and exclusion criteria.

Inclusion criteria

  • Candidate for surgical intervention with breast reconstruction as part of the surgical plan
  • 22 years of age or older;
  • Able to understand and provide informed consent with HIPAA authorization.
  • Able to read and understand in English.

Exclusion criteria

Exclusion Criteria:

  • Subjects who might need a legally-authorized representative
  • Subjects who possess diminished mental capabilities
  • Conditions that preclude imaging (excessive scarring, tattoos in surgical field, Fitzpatrick Scale VI)
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
6 participants (actual)
Patient registry
No

Groups and cohorts

  • breast reconstruction surgery patients

    Patients will be imaged with imaging device (Presygen™/si-1) during surgical procedure. Image surgical area. Surgical procedure will follow standard of care. No clinical decisions will be made on device readings. A surgeon will complete a survey regarding his assessment of the imaging device.

    Device: Image surgical area

Interventions

  • DeviceImage surgical area

    Image surgical area

    Also known as: Questionnaire on ease of use and general opinion

06

What researchers measure

Primary outcomes

  1. Photographic, electronic and descriptive comparative analysis of superficial tissue oxygen saturation using Presygen™/si-1 for breast reconstruction subjects.

    Quantitative measures of tissue oxygen saturation for discrete locations on superficial tissue.

    Time frame: 24 hours.

Secondary outcomes

  1. Quantitative survey providing surgeon assessment of work station during procedure.

    completion of basic questionnaire

    Time frame: 24 hours

07

Study locations

1 site
  • Englewood Hospital and Medical Cetner
    Englewood, New Jersey 07631, United States
08

References and documents

Publications

  • Pestana IA, Coan B, Erdmann D, Marcus J, Levin LS, Zenn MR. Early experience with fluorescent angiography in free-tissue transfer reconstruction. Plast Reconstr Surg. 2009 Apr;123(4):1239-1244. doi: 10.1097/PRS.0b013e31819e67c1. PubMed 19337092 ↗
  • Colwell AS, Craft RO. Near-infrared spectroscopy in autologous breast reconstruction. Clin Plast Surg. 2011 Apr;38(2):301-7. doi: 10.1016/j.cps.2011.03.014. PubMed 21620154 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03715270
Lead sponsor
Christie Medical Holdings, Inc.
Responsible party
Sponsor
First posted
Oct 23, 2018
Start date
Jan 30, 2019
Primary completion
Jun 5, 2019
Completion
Jun 5, 2019
Last update
Jun 10, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion